Ebiratide is a synthetic peptide derived from human lactoferrin with immunomodulatory and anti-inflammatory properties. It has been investigated for enhancing hematopoiesis and tissue repair in various clinical conditions. The directory classifies it as a clinical API with a peptide source/manufacturing origin. Other names for this substance include Ebiratidum and Ebiratida. Its PubChem CID is 6918103.
Ebiratide
| CAS No | 105250-86-0 |
|---|---|
| Molecular Formula | C48H73N11O10S |
| Molecular Weight | 996.2 g/mol |
| Synonyms | (4S)-5-[[(2S)-1-[[(2S)-1-[[(2R)-6-amino-1-[[(2S)-1-(8-aminooctylamino)-1-oxo-3-phenylpropan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-[[(2S)-2-amino-4-methylsulfonylbutanoyl]amino]-5-oxopentanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ebiratide is a synthetic peptide derived from human lactoferrin with immunomodulatory and anti-inflammatory properties. It has been investigated for enhancing hematopoiesis and tissue repair in various clinical conditions.
The listed CAS number is 105250-86-0.
The listed molecular formula is C48H73N11O10S.
The listed molecular weight is 996.2 g/mol.
(4S)-5-[[(2S)-1-[[(2S)-1-[[(2R)-6-amino-1-[[(2S)-1-(8-aminooctylamino)-1-oxo-3-phenylpropan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-[[(2S)-2-amino-4-methylsulfonylbutanoyl]amino]-5-oxopentanoic acid.
The source lists Ebiratidum and Ebiratida.